These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6136640)

  • 1. Pharmacology of L-prolyl-L-leucyl-glycinamide (PLG): a review.
    Mishra RK; Chiu S; Chiu P; Mishra CP
    Methods Find Exp Clin Pharmacol; 1983; 5(4):203-33. PubMed ID: 6136640
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolyl-leucyl-glycinamide shares some effects with oxytocin but decreases oxytocin levels.
    Petersson M; Uvnäs-Moberg K
    Physiol Behav; 2004 Dec; 83(3):475-81. PubMed ID: 15581670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of prolyl-leucyl-glycinamide on behavioral and visceral functions in dogs].
    Pastukhov VA; Lozhkina TK
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(2):372-3. PubMed ID: 1974376
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolyl-leucyl-glycine amide (PLG) and thyrotropin-releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
    Plotnikoff NP
    Prog Brain Res; 1975; 42():11-23. PubMed ID: 730
    [No Abstract]   [Full Text] [Related]  

  • 5. L-prolyl-L-leucyl-glycinamide analogues--a new class of peptide antihypertensives.
    Rajakumar G; Singh AN; Naas F; Chiu S; Kwan CY; Johnson RL; Mishra RK
    J Hypertens Suppl; 1986 Dec; 4(5):S106-8. PubMed ID: 2883271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of L-prolyl-L-leucyl-glycinamide.
    Ott MC; Mishra RK; Johnson RL
    Brain Res; 1996 Oct; 737(1-2):287-91. PubMed ID: 8930377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of PLG (L-prolyl-L-leucyl-glycinamide) in treating Parkinson's disease].
    Pan JB
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):205-8. PubMed ID: 2866940
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the oxytocin fragment prolyl-leucyl-glycinamide on sexual behavior in the rat.
    Gorzalka BB; Luck KA; Tanco SA
    Pharmacol Biochem Behav; 1991 Feb; 38(2):273-9. PubMed ID: 1676168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are the pharmacological effects of L-prolyl-L-leucyl-glycinamide (PLG) mediated through specific receptor mechanisms?
    Chiu S; Wong YW; Wan YP; Chiu P; Mishra RK
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):739-42. PubMed ID: 6141616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-dopa potentiating analogs of Pro-Leu-Gly-NH2 with oral efficacy.
    Albrecht HP; Hofman HP; Klebe G; Kreiskott H
    Boll Chim Farm; 1991 Feb; 130(2):55-9. PubMed ID: 1678611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal fragments of oxytocin (prolyl-leucyl-glycinamide and Z-prolyl-D-leucine) attenuate the development of tolerance to ethanol.
    Szabó G; Kovács GL; Székeli S; Baláspiri L; Telegdy G
    Acta Physiol Hung; 1987; 69(1):115-22. PubMed ID: 2884803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and dopamine receptor modulating activity of diketopiperazine peptidomimetics of L-prolyl-L-leucylglycinamide.
    Baures PW; Ojala WH; Costain WJ; Ott MC; Pradhan A; Gleason WB; Mishra RK; Johnson RL
    J Med Chem; 1997 Oct; 40(22):3594-600. PubMed ID: 9357526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl-leucyl-glycinamide (PLG): inhibition of offensive aggression in mice.
    Kavaliers M; Hirst M
    Life Sci; 1986 Nov; 39(19):1729-35. PubMed ID: 2877382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of prolyl-leucyl-glycinamide on the myoelectric activity of the gastrointestinal tract of the dog].
    Pastukhov VA; Lozhkina TK
    Fiziol Zh SSSR Im I M Sechenova; 1986 Apr; 72(4):555-8. PubMed ID: 2872088
    [No Abstract]   [Full Text] [Related]  

  • 15. Antagonism of morphine-induced catalepsy by L-prolyl-L-leucyl-glycinamide.
    Chiu S; Mishra RK
    Eur J Pharmacol; 1979 Jan; 53(2):119-25. PubMed ID: 32058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by L-prolyl-L-leucyl-glycinamide (PLG) of alpha-melanocyte stimulating hormone release from hypothalamic slices.
    Scimonelli T; Celis ME
    Peptides; 1982; 3(6):885-9. PubMed ID: 6132363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of apomorphine-induced stereotypies by naloxone and L-prolyl-L-leucyl-glycinamide.
    Quock RM; Lucas TS; Hartl TJ
    Pharmacol Biochem Behav; 1983 Jul; 19(1):49-52. PubMed ID: 6137836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolyl-leucyl-glycinamide, thyrotropin-releasing hormone and beta-endorphin-(10-16), like antidepressants, antagonize melatonin-induced behavioural changes in rats.
    Hatta K; Wolterink G; Van Ree JM
    Eur J Pharmacol; 1995 Sep; 284(3):327-30. PubMed ID: 8666016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of L-prolyl-L-leucyl-glycinamide.
    Khalil EM; Ojala WH; Pradhan A; Nair VD; Gleason WB; Mishra RK; Johnson RL
    J Med Chem; 1999 Feb; 42(4):628-37. PubMed ID: 10052970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amide.
    Kostrzewa RM; Kastin AJ; Sobrian SK
    Pharmacol Biochem Behav; 1978 Sep; 9(3):375-8. PubMed ID: 30981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.